Quadruple-responsive nanoparticle-mediated targeted combination chemotherapy for metastatic breast cancer.

Abstract

The synergism of combination chemotherapy can only be achieved under specific drug ratios. Herein, hyaluronic acid (HA)-functionalized regenerated silk fibroin-based nanoparticles (NPs) were used to concurrently deliver curcumin (CUR) and 5-fluorouracil (5-FU) at various weight ratios (3.3\u2009:\u20091, 1.6\u2009:\u20091, 1.1\u2009:\u20091, 1\u2009:\u20091, and 1\u2009:\u20091.2) to breast tumor cells. The generated HA-CUR/5-FU-NPs were found to have desirable particle sizes (around 200 nm), narrow size distributions, and negative zeta potentials (about -26.0 mV). Interestingly, these NPs showed accelerated drug release rates when they were exposed to buffers that mimicked the multi-hallmarks in the tumor microenvironment (pH/hydrogen peroxide/glutathione/hyaluronidase). The surface functionalization of NPs with HA endowed them with in vitro and in vivo breast tumor-targeting properties. Furthermore, we found that the co-loading of CUR and 5-FU in HA-functionalized NPs exhibited obvious synergistic anti-cancer, pro-apoptotic, and anti-migration effects, and the strongest synergism was found at the CUR/5-FU weight ratio of 1\u2009:\u20091.2. Most importantly, mice experiments revealed that HA-CUR/5-FU-NPs (1\u2009:\u20091.2) showed a superior anti-cancer activity against metastatic breast cancer compared to the single drug-loaded NPs and non-functionalized CUR/5-FU-NPs (1\u2009:\u20091.2). Collectively, these results demonstrate that HA-CUR/5-FU-NPs (1\u2009:\u20091.2) can be exploited as a robust nanococktail for the treatment of breast cancer and its lung metastasis.